The Phase III, double-blind, parallel-group controlled study of amlodipine 10mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5mg once daily

Journal of Human Hypertension

Volumn 23, Issue 8, 2009, Pages 521-529

  Fujiwara, T ^a   Ii, Y ^a   Hatsuzawa, J ^a   Murase, H ^a   Watanabe, T ^a   Murakami, M ^a   Kimura, N ^a   Buch, J ^a   Tsuchihashi, T ^b   Saruta, T ^c  

^a PFIZER INC   (United States)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMBROXOL; AMLODIPINE; CHINESE DRUG; ETIZOLAM; GLIMEPIRIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MECOBALAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SERRATIOPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; HEART PALPITATION; HOT FLUSH; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; VERTIGO;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EDEMA; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67849097718     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.161     Document Type: Article

References (22)

1. Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Ralph RT. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: A multicentre study. J Hypertens 1993; 11: 103-113.
2. Katayama S, Inaba M, Morita T, Awata T, Shimamoto K, Kikkawa R. Blood pressure control in Japanese hypertensives with or without type 2 diabetes Mellitus. Hypertens Res (236); 2000: 601-605.
3. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA 2002; 288: 2981-2997.
4. Julius S, Kjeldsen SE, Weber M, Brunner HS, Ekman S, Hansson L et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomized trial. Lancet 2004; 363: 2022-2031.
5. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005; 366: 895-906.
6. Taylor SH, Chen M, Lee SJK, Koanantakul B, Zhu JR, Santoso T et al. Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an Asian multinational population. Clin Drug Invest 1998; 16: 177-185.
7. Tomlinson B, Woo J, Thomas GN, Chau YM, Critchley JA. Randomized, controlled parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult Chinese patients with hypertension. Clin Ther 2004; 26 1292-1304.
8. Wang X, Gong L, Guo J. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension. J Hypertens 1998; 16(suppl. 4): S43-S47.
9. Wu SC, Liu CP, Chiang HT, Lin SL. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients. Heart Vessels 2004; 19: 13-18.
10. Cheung BMY, Lau C, Wu B. Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension. Clin Ther 1998; 20: 1159-1169.
11. Lau CP, Cheung BMY. Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-tomoderate hypertension: A randomized double-blind study. J Cardiovasc Pharmacol 1996; 28: 328-331.
12. Ding YA, Chang SM, Chou TC. Comparison of the effect of amlodipine and quinapril on ambulatory blood pressure in hypertension. J Hum Hypertens 1995; 9: 637-641.
13. Ko GTC, Chan HCK, Chan CHS. Blood pressure reduction and tolerability of amlodipine versus nifedipine retard in Chinese patients with type 2 diabetes mellitus and hypertension: A randomized 1-year clinical trial. Int J Clin Pharmacol Ther 2001; 39: 331-335.
14. Hwang JJ, Chen JJ. Once-daily amlodipine on ambulatory blood pressure and regression of left ventricular hypertrophy in patients with mild to moderate essential hypertension. JAMA SE Asia 1995; 11 (Suppl 4): 10-15.
15. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-1114.
16. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GBJ, Miller ME et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102 1503-1510.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The national high blood pressure education program coordination committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289: 2560-2572.
18. Guideline Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
19. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999; 341(19): 1447-1457.
20. Brown MJ, Palmer RC, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-372.
21. Hansson L, Lindholm LH, Ekbom T, Dahof B, Lanke J, Schersten B et al. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in old patients with hypertension-2 study. Lancet 1999; 354: 1751-1756.
22. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K et al. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks. Hypertension 2008; 51: 393-398.